204P Deciphering the crosstalk between tumor and circulating immune microenvironment in advanced NSCLC patients undergoing immunotherapy
Exploring the interaction between tissue and circulating immune descriptors may represent a critical step in our understanding of cancer immunity cycle to dissect distinct immunotherapy (IO) outcomes. Thus, we determined whether a comprehensive immune profiling, including tumor immune microenviroment (TIME) and peripheral blood (PB) might offer an “holistic” view of patient-specific immune background, potentially leading to new personalized therapeutic strategies.
Authors
- P. Tamarozzi
- Federica Pecci (ORCID: https://orcid.org/0009-0000-9289-2007)
- L. Gnetti
- P. Bordi
- Alessandra Dodi (ORCID: https://orcid.org/0000-0002-4029-2170)
- M. Tiseo
- Giulia Mazzaschi (ORCID: https://orcid.org/0000-0003-4019-579X)
- A. Leonetti
- Simona D’Agnelli (ORCID: https://orcid.org/0000-0001-5396-9542)
- N. Sverzellati
- M. Pluchino
- F. Quaini
- R. Minari
- F. Perrone
- M. Tessitori
Institutions
- University of Parma (IT)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2024.100957
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00